Skip to content

Drug interactions

Lansoprazole + Lenacapavir

Severity: Minor

Lansoprazole and Lenacapavir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor, so lansoprazole exposure may rise somewhat. Because of the long half-life of subcutaneous lenacapavir, this effect can persist for months, but the clinical significance is expected to be low.

What this interaction means in plain words

Lansoprazole and Lenacapavir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lansoprazole belongs to Gastrointestinal Tract; Lenacapavir belongs to Anti Virals.

Evidence level: Low

Why it happens

Lenacapavir inhibits CYP3A4, decreasing lansoprazole metabolism.

What to do

No dose change is routinely needed; be aware that the effect can persist after the last injection.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lansoprazole and Lenacapavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lansoprazole with Lenacapavir?

MediHelp rates the interaction as minor. Lansoprazole and Lenacapavir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lenacapavir is a moderate CYP3A inhibitor, so lansoprazole exposure may rise somewhat. Because of the long half-life of subcutaneous lenacapavir, this effect can persist for months, but the clinical significance is expected to be low.

How serious is the interaction between Lansoprazole and Lenacapavir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is routinely needed; be aware that the effect can persist after the last injection.

What other medicines interact with Lansoprazole?

MediHelp also lists interactions of Lansoprazole with, for example, Mavacamten, Rilpivirine, Acalabrutinib. The full list is on the Lansoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in